ID   RBL1_MOUSE              Reviewed;        1063 AA.
AC   Q64701; Q3U1D4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   07-APR-2021, entry version 179.
DE   RecName: Full=Retinoblastoma-like protein 1;
DE   AltName: Full=107 kDa retinoblastoma-associated protein;
DE            Short=p107;
DE   AltName: Full=pRb1;
GN   Name=Rbl1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ;
RX   PubMed=8661722; DOI=10.1007/s003359900102;
RA   Huppi K., Siwarski D., Mock B.A., Dosik J., Hamel P.A.;
RT   "Molecular cloning, chromosomal mapping, and expression of the mouse p107
RT   gene.";
RL   Mamm. Genome 7:353-355(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).
RX   PubMed=7490090; DOI=10.1006/geno.1995.1184;
RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;
RT   "Developmental expression of p107 mRNA and evidence for alternative
RT   splicing of the p107 (RBL1) gene product.";
RL   Genomics 28:520-529(1995).
RN   [3]
RP   SEQUENCE REVISION.
RA   Kim K.K., Soonpaa M.H., Wang H., Field L.J.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NOD; TISSUE=Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   INTERACTION WITH USP4.
RX   PubMed=11571651; DOI=10.1038/sj.onc.1204823;
RA   Blanchette P., Gilchrist C.A., Baker R.T., Gray D.A.;
RT   "Association of UNP, a ubiquitin-specific protease, with the pocket
RT   proteins pRb, p107 and p130.";
RL   Oncogene 20:5533-5537(2001).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH KMT5B AND KMT5C.
RX   PubMed=15750587; DOI=10.1038/ncb1235;
RA   Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M.,
RA   Cotter S.E., Eguia R., Dean D.C., Esteller M., Jenuwein T., Blasco M.A.;
RT   "Role of the RB1 family in stabilizing histone methylation at constitutive
RT   heterochromatin.";
RL   Nat. Cell Biol. 7:420-428(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1036, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; SER-959 AND SER-1036,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Key regulator of entry into cell division (By similarity).
CC       Directly involved in heterochromatin formation by maintaining overall
CC       chromatin structure and, in particular, that of constitutive
CC       heterochromatin by stabilizing histone methylation (PubMed:15750587).
CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,
CC       leading to epigenetic transcriptional repression (PubMed:15750587).
CC       Controls histone H4 'Lys-20' trimethylation (PubMed:15750587). Probably
CC       acts as a transcription repressor by recruiting chromatin-modifying
CC       enzymes to promoters (PubMed:15750587). Potent inhibitor of E2F-
CC       mediated trans-activation (By similarity). May act as a tumor
CC       suppressor (By similarity). {ECO:0000250|UniProtKB:P28749,
CC       ECO:0000269|PubMed:15750587}.
CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at
CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,
CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (By similarity). The complex exists
CC       in quiescent cells where it represses cell cycle-dependent genes (By
CC       similarity). It dissociates in S phase when LIN9, LIN37, LIN52 and
CC       LIN54 form a subcomplex that binds to MYBL2 (By similarity). Interacts
CC       with AATF (By similarity). Interacts with KDM5A (By similarity).
CC       Interacts with KMT5B and KMT5C (PubMed:11571651). Interacts with USP4
CC       (PubMed:15750587). Interacts with RBBP9 (By similarity).
CC       {ECO:0000250|UniProtKB:D3ZS28, ECO:0000250|UniProtKB:P28749,
CC       ECO:0000269|PubMed:11571651, ECO:0000269|PubMed:15750587}.
CC   -!- INTERACTION:
CC       Q64701; Q155P7: Cenpf; NbExp=3; IntAct=EBI-1213109, EBI-2211248;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q64701-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q64701-2; Sequence=VSP_005537, VSP_005538;
CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal heart and liver.
CC       Expressed at low levels in all other fetal tissues except skeletal
CC       muscle. High levels in neonatal spleen and thymus with low levels in
CC       other tissues. In adult, highly expressed in testis. Barely detectable
CC       in other tissues.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in fetal tissues. Expression
CC       markedly decreased in adult.
CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on
CC       Thr-332, Ser-640, Ser-959 and Ser-970 by CDK4.
CC       {ECO:0000250|UniProtKB:P28749}.
CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U33320; AAB18279.1; -; mRNA.
DR   EMBL; U27177; AAB53235.1; -; mRNA.
DR   EMBL; U27178; AAB53236.1; -; mRNA.
DR   EMBL; AK156055; BAE33564.1; -; mRNA.
DR   EMBL; AL669828; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS16974.1; -. [Q64701-1]
DR   PIR; I49328; I49328.
DR   RefSeq; NP_001132988.1; NM_001139516.1. [Q64701-2]
DR   RefSeq; NP_035379.2; NM_011249.2. [Q64701-1]
DR   BioGRID; 202819; 28.
DR   CORUM; Q64701; -.
DR   IntAct; Q64701; 3.
DR   STRING; 10090.ENSMUSP00000029170; -.
DR   iPTMnet; Q64701; -.
DR   PhosphoSitePlus; Q64701; -.
DR   EPD; Q64701; -.
DR   jPOST; Q64701; -.
DR   PaxDb; Q64701; -.
DR   PeptideAtlas; Q64701; -.
DR   PRIDE; Q64701; -.
DR   ProteomicsDB; 300314; -. [Q64701-1]
DR   ProteomicsDB; 300315; -. [Q64701-2]
DR   Antibodypedia; 11876; 416 antibodies.
DR   Ensembl; ENSMUST00000029170; ENSMUSP00000029170; ENSMUSG00000027641. [Q64701-1]
DR   GeneID; 19650; -.
DR   KEGG; mmu:19650; -.
DR   UCSC; uc008noq.2; mouse. [Q64701-1]
DR   UCSC; uc008nos.2; mouse. [Q64701-2]
DR   CTD; 5933; -.
DR   MGI; MGI:103300; Rbl1.
DR   eggNOG; KOG1010; Eukaryota.
DR   GeneTree; ENSGT00950000183202; -.
DR   HOGENOM; CLU_008943_0_1_1; -.
DR   InParanoid; Q64701; -.
DR   OMA; ANVECNL; -.
DR   TreeFam; TF105568; -.
DR   Reactome; R-MMU-1538133; G0 and Early G1.
DR   Reactome; R-MMU-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.
DR   BioGRID-ORCS; 19650; 3 hits in 53 CRISPR screens.
DR   ChiTaRS; Rbl1; mouse.
DR   PRO; PR:Q64701; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q64701; protein.
DR   Bgee; ENSMUSG00000027641; Expressed in optic fissure and 237 other tissues.
DR   Genevisible; Q64701; MM.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:MGI.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008134; F:transcription factor binding; ISO:MGI.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:MGI.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0051302; P:regulation of cell division; IEA:InterPro.
DR   GO; GO:0043550; P:regulation of lipid kinase activity; ISO:MGI.
DR   CDD; cd00043; CYCLIN; 1.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR002720; RB_A.
DR   InterPro; IPR002719; RB_B.
DR   InterPro; IPR015030; RB_C.
DR   InterPro; IPR028309; RB_fam.
DR   InterPro; IPR024599; RB_N.
DR   InterPro; IPR028310; RBL1.
DR   PANTHER; PTHR13742; PTHR13742; 1.
DR   PANTHER; PTHR13742:SF20; PTHR13742:SF20; 1.
DR   Pfam; PF11934; DUF3452; 1.
DR   Pfam; PF01858; RB_A; 1.
DR   Pfam; PF01857; RB_B; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01367; DUF3452; 1.
DR   SMART; SM01368; RB_A; 1.
DR   SMART; SM01369; Rb_C; 1.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Chromatin regulator; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Tumor suppressor.
FT   CHAIN           1..1063
FT                   /note="Retinoblastoma-like protein 1"
FT                   /id="PRO_0000167840"
FT   REGION          383..944
FT                   /note="Pocket; binds T and E1A"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   REGION          383..584
FT                   /note="Domain A"
FT                   /evidence="ECO:0000305"
FT   REGION          585..779
FT                   /note="Spacer"
FT                   /evidence="ECO:0000305"
FT   REGION          780..944
FT                   /note="Domain B"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         332
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         369
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         385
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         650
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         748
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         761
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         959
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         983
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         992
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         1004
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28749"
FT   MOD_RES         1036
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         592..594
FT                   /note="IFP -> SQG (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:7490090"
FT                   /id="VSP_005537"
FT   VAR_SEQ         595..1063
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:7490090"
FT                   /id="VSP_005538"
FT   CONFLICT        26
FT                   /note="Q -> P (in Ref. 1; AAB18279)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        430
FT                   /note="I -> T (in Ref. 1; AAB18279)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        863
FT                   /note="I -> R (in Ref. 2; AAB53235)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        989
FT                   /note="A -> C (in Ref. 1; AAB18279)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1063 AA;  119456 MW;  85BEA8EC064EC06E CRC64;
     MFEDEPHAEG AAAVAAAREA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVIHWLA
     CSLYVACRKS IIPTVGKGVM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE
     RIERLERNFE VSTVIFKKFE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL
     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRR DLLNPSFKGL PSDFHAPDFK
     AAEEPPCIIA VLCDLHDGLL VEAKGIKEHY FKPYISKLFD KKILKGECLL DLSSFTDNSK
     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTADT PFGKLTSQAS VECNLQQHFE
     KKRSFAPSTP LTGRRYLQEK EAVTTPVASA TQSVSRLQSI VAGLKSAPSE QLLNIFESCM
     RNPMGNIIKI VKGIGETFCQ HYTQSTDKQP GSHIDFAVNR LKLAEILYYK ILETIMVQET
     RRLHGMDMSV LLEQDIFHKS LMACCLEIVL FAYSSPRTFP WIIEVLDLQP FYFYKVIEVV
     IRSEEGLSRD MVKHLNSIEE QILESLAWTN NSALWEALHA SANRVPSCEE VIFPNNFEIG
     NGGNVQGHLP MMPMSPIIHP RVKEVRTDSG SLRQDMQPLS PISVHERYSS PAAGSAKRRL
     FGDDPPKDTL MDKIMAEGTK LKIAPSSVTA ESLSISPGQA LLTMATTTVT GTTGRKVTVP
     LHGIANDAGE ITLVPISMNP TQESTAESPV SLTAQSLIGT SPKQTHLTKA QDAHLTGVSK
     PKRTGSLALF YRKVYHLASV RLRDLCLKLD VSNELRRKIW TCFEFTLVHC PDLMKDRHLD
     QLLLCAFYIM AKVTKEERTF QEIMKSYRNQ PQANSHVYRS VLLKSIPGGV VVYNGDCEMT
     DGDIEDATKT PNCSSEPVKE ERGDLIKFYN TVYVGRVKSF ALKYDLSNQD HIMDAPPLSP
     FPHIKQQPGS PRRISQQHSL YVSPHKNGAG LTPRSALLYK FNGSPSKSLK DINNMIRQGE
     QKTKKRVIAI SGDADSPAKR LCQENDDVLL KRLQDVVSER ANH
//
